BackTable Urology
Ep. 210 Personalizing ADT Across the Prostate Cancer Spectrum with Dr. Rana McKay
Aditya Bagrodia
You know, while I think we like to get those durations of ADT in for the intermediate risk patients and for the high risk patients, it's kind of a little bit of a conversation, right? If they're completely miserable and life is not worth living, then it's not like we're going to strap you down and get you two years in.
0
💬
0
Comments
Log in to comment.
There are no comments yet.